| Summary of Carrying Values and Fair Values of Financial Instruments |
The following table presents the carrying amounts and fair values of the Company’s financial instruments as of March 31, 2026.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2026 |
|
(Dollars in thousands) |
|
Carrying
Amount |
|
|
Fair
Value |
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
Financial assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents, and federal funds sold (1) |
|
$ |
138,649 |
|
|
$ |
138,649 |
|
|
$ |
137,899 |
|
|
$ |
750 |
|
|
$ |
— |
|
Investment securities |
|
|
67,934 |
|
|
|
67,934 |
|
|
|
— |
|
|
|
67,934 |
|
|
|
— |
|
Loans held for investment, net of allowance |
|
|
2,490,513 |
|
|
|
2,503,325 |
|
|
|
— |
|
|
|
— |
|
|
|
2,503,325 |
|
Loans held for sale, at lower of amortized cost or fair value |
|
|
10,786 |
|
|
|
10,786 |
|
|
|
— |
|
|
|
— |
|
|
|
10,786 |
|
Accrued interest receivable |
|
|
19,261 |
|
|
|
19,261 |
|
|
|
19,261 |
|
|
|
— |
|
|
|
— |
|
Equity securities (2) |
|
|
1,776 |
|
|
|
1,776 |
|
|
|
1,776 |
|
|
|
— |
|
|
|
— |
|
Financial liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Funds borrowed (3) |
|
|
2,395,460 |
|
|
|
2,407,187 |
|
|
|
— |
|
|
|
2,407,187 |
|
|
|
— |
|
Accrued interest payable |
|
|
5,635 |
|
|
|
5,635 |
|
|
|
5,635 |
|
|
|
— |
|
|
|
— |
|
(1)Includes federal funds sold and interest bearing deposits in other banks. (2)Included within other assets on the balance sheet. (3)Excludes deferred financing costs of $8.2 million as of March 31, 2026. The following table presents the carrying amounts and fair values of the Company’s financial instruments as of December 31, 2025.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2025 |
|
(Dollars in thousands) |
|
Carrying
Amount |
|
|
Fair
Value |
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
Financial assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents, and federal funds sold (1) |
|
$ |
201,564 |
|
|
$ |
201,564 |
|
|
$ |
200,814 |
|
|
$ |
750 |
|
|
$ |
— |
|
Investment securities |
|
|
60,183 |
|
|
|
60,183 |
|
|
|
— |
|
|
|
60,183 |
|
|
|
— |
|
Loans held for investment, net of allowance |
|
|
2,436,916 |
|
|
|
2,421,988 |
|
|
|
— |
|
|
|
— |
|
|
|
2,421,988 |
|
Loans held for sale, at lower of amortized cost or fair value |
|
|
15,144 |
|
|
|
15,144 |
|
|
|
— |
|
|
|
— |
|
|
|
15,144 |
|
Accrued interest receivable |
|
|
19,401 |
|
|
|
19,401 |
|
|
|
19,401 |
|
|
|
— |
|
|
|
— |
|
Equity securities (2) |
|
|
1,787 |
|
|
|
1,787 |
|
|
|
1,787 |
|
|
|
— |
|
|
|
— |
|
Financial liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Funds borrowed (3) |
|
|
2,410,016 |
|
|
|
2,431,011 |
|
|
|
— |
|
|
|
2,431,011 |
|
|
|
— |
|
Accrued interest payable |
|
|
6,319 |
|
|
|
6,319 |
|
|
|
6,319 |
|
|
|
— |
|
|
|
— |
|
(1)Includes federal funds sold and interest bearing deposits in other banks. (2)Included within other assets on the balance sheet. (3)Excludes deferred financing costs of $8.4 million as of December 31, 2025.
|